Our work

Advocacy

Inequalities in care persist across Europe for patients living with dysimmune inflammatory neuropathy (GBS, CIDP, MMN, LSS, Anti-MAG, MFS…). Access to diagnosis, treatment and patient follow-up remains a major challenge, and there is still a lot to do. In the run-up to the European Parliament elections in June 2024, EPODIN

Read more »

Advocacy

Inequalities in care persist across Europe for patients living with dysimmune inflammatory neuropathy (GBS, CIDP, MMN, LSS, Anti-MAG, MFS…). Access to diagnosis, treatment and patient

EURO-NMD is a European Reference Network for the thematic grouping of rare neuromuscular diseases.

Good Practices

The experts and patients conclude these videos by emphasizing the...